Advertisement
UK markets open in 6 hours 20 minutes

  • NIKKEI 225

    38,187.92
    +635.76 (+1.69%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • CRUDE OIL

    83.46
    +0.10 (+0.12%)
     

  • GOLD FUTURES

    2,336.10
    -6.00 (-0.26%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,480.40
    -258.93 (-0.48%)
     

  • CMC Crypto 200

    1,430.44
    +15.68 (+1.11%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Moderna Completes Enrollment in Phase 2 COVID-19 Vaccine Study; Phase 3 Start on Track

Brian Orelli, PhD, The Motley Fool
·2-min read
Moderna Completes Enrollment in Phase 2 COVID-19 Vaccine Study; Phase 3 Start on Track

Moderna (NASDAQ: MRNA) is one step closer to getting its COVID-19 vaccine, mRNA-1273, on the market. The biotech completed enrollment of 300 older adults, 55 years and older, in a phase 2 clinical trial. The other half of the clinical trial, 300 younger adults ages 18-55, was completed last month, but the older-adult cohort took longer to enroll because it was set up in two stages with a pause after 50 patients to observe safety.

Continue reading